Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Oral Thin Films Market Growth in 2025?

The market size for oral thin films has seen a fast-paced expansion in the recent past. The market is predicted to escalate from $4.48 billion in 2024 to an astounding $5.03 billion in 2025, clocking a compound annual growth rate (CAGR) of 12.2%. The significant progression during the previously recorded period can be traced back to factors such as patient compliance, the involvement of pediatric and geriatric patients, swift drug delivery, prevalence of chronic diseases, and over-the-counter (otc) medications.

What Is the Forecast for the Oral Thin Films Market Size Through 2029?

The market for oral thin films is projected to experience a significant expansion in the upcoming years, reaching an estimated $8.72 billion by 2029, with a Compound Annual Growth Rate (CAGR) of about 14.7%. The anticipated growth during this period could be linked to specialised pharmaceuticals, precision medicine, mental health medications, oral vaccines, and telemedicine services. Noteworthy trends during this forecast period are expected to encompass drug delivery technologies, remote healthcare, improvement of bioavailability, travel-friendly and convenient usage, and hypoallergenic formulations.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6067&type=smp

What are the Key Market Players in Oral Thin Films Market and How They’re Evolving?

Major companies operating in the oral thin films market include ZIM Laboratories Limited, NAL Pharma, Cure Pharmaceutical Holding Corp., IntelGenx Corp., Kyu Kyu Pharmaceutical Co. Ltd., Sunovion Pharmaceuticals Inc., Seoul Pharma Co. Ltd., Aquestive Therapeutics Inc., Shilpa Therapeutics Pvt. Ltd., Mylan Inc., LIVKON Pharmaceuticals Pvt. Ltd., Panacea Biotec Ltd., Adare Pharmaceuticals Inc., APR Applied Pharma Research SA, BioDelivery Sciences International Inc., Sumitomo Dainippon Pharma Co. Ltd., Indivior PLC, LTS Lohmann Therapie-Systeme AG, Tesa Labtec GmbH, Pfizer Inc., Sanofi S.A., Merck & Co. Inc., Novartis International AG, Roche Holding AG, Johnson & Johnson, GlaxoSmithKline plc, Bayer AG, Eli Lilly and Company, AbbVie Inc., Bristol-Myers Squibb Company, Novo Nordisk A/S, AstraZeneca plc

What Are the Primary Growth Drivers in the Oral Thin Films Market?

The growth of the oral thin film market is being primarily driven by the increasing demand for thin film drug delivery systems. These thin films have been found to be a great alternative to traditional dosage forms due to their convenience, self-administration, and fast dissolving nature, making them a versatile platform for drug delivery. To be consumed orally, thin films do not necessitate the ingestion of water for a drug’s absorption. Being more patient-friendly due to its swift dissolution rate, the oral thin film (OTF) sees an escalating demand. Notably, in the United States, more than half of the population suffers from cardiovascular diseases. A report from The American Cancer Society, a non-profit organization based in the US, declared in January 2023 that at least 42% of new cancer cases diagnosed in the US, amounted to approximately 820,000 in 2023 and 840,000 in 2024. These figures clearly delineate the medical need for refined drug delivery techniques for efficacious treatments. Consequently, this increased demand for thin film drug delivery systems amplifies the growth potential of the oral thin film market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6067&type=smp

What Are the Leading Segments in the Global Oral Thin Films Industry?

The oral thin films market covered in this report is segmented –

1) By Type: Sublingual Film, Fast Dissolving Dental/Buccal Film

2) By Disease Indication: Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, Other Disease Indication

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

Subsegments:

1) By Sublingual Film: Drug Delivery Films, Nutritional Supplement Films

2) By Fast Dissolving Dental Or Buccal Film: Over-the-Counter (OTC) Products, Prescription Products

What Are the Key Market Trends in the Oral Thin Films Industry?

Key players in the oral thin films market, such as Rizaport, are concentrating on groundbreaking products to increase their market revenue. The active ingredient of the product Rizaport is rizatriptan benzoate, a 5-HT1 receptor agonist, that’s also an active ingredient in Merck & Co.’s Maxalt. In February 2024, the drug formulation company based in the US, CD Formulation, introduced the oral thin film technology. This technology provides easy administration, specifically benefiting those patients who have trouble swallowing. By dissolving directly in the oral cavity and bypassing the digestive system, it ensures quicker absorption leading to faster onset of action. This innovative drug delivery system not only increases bioavailability but also enables accurate dosing for personalized therapy. It eventually improves convenience and medication compliance, particularly in emergency scenarios.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report

What Is the Regional Outlook for the Oral Thin Films Market?

North America was the largest region in the oral thin film market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral thin films market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6067

This Report Delivers Insight On:

1. How big is the oral thin films market, and how is it changing globally?

2. Who are the major companies in the oral thin films market, and how are they performing?

3. What are the key opportunities and risks in the oral thin films market right now?

4. Which products or customer segments are growing the most in the oral thin films market?

5. What factors are helping or slowing down the growth of the oral thin films market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model